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A B S T R A C T
Introduction. The specific affective experiences related to changes in various aspects of female sexual function have
received little attention as most prior studies have focused instead on the role of clinical mood and anxiety disorders
and their influence on sexual dysfunction.
Aim. We sought to understand the transaction between daily affect and female sexual function in effort to provide
a more nuanced understanding of the interplay between affective and sexual experiences.
Methods. The present study used a 2-week daily diary approach to examine same-day and temporal relations
between positive and negative affect states and sexual function in young women.
Main OutcomeMeasures. We examined the unique relations between positive (i.e., joviality, serenity, self-assurance)
and negative (i.e., fear, sadness, hostility) affects and female sexual response (i.e., desire, subjective arousal, vaginal
lubrication, orgasmic function, and sexual pain) while controlling for higher order sexual distress, depression, and
anxiety, as well as age effects and daily menstruation.
Results. Analyses revealed different aspects of both positive and negative affects to be independently related to sexual
response indices. Specifically, results indicated that joviality was related to same-day sexual desire and predicted
increased desire the following day. This latter relation was partially mediated by sexual activity. Further, greater
sexual desire predicted next-day calmness, which was partially mediated by sexual activity. Notably, fear was related
to same-day subjective arousal, lubrication, orgasmic function, and vaginal pain, whereas poorer orgasmic function
predicted greater next-day sadness.
Conclusions. These findings describe the manner in which changes in affect correspond to variations in female sexual
function, thus highlighting the inextricability of mental and sexual health. Further, these findings may offer insight
into the progression of normative levels of affect and sexual function as they develop into comorbid depression,
anxiety, and sexual dysfunction. Kalmbach DA and Pillai V. Daily affect and female sexual function. J Sex Med
2014;11:2938–2954.
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Introduction
P revious investigations have demonstrated thatpoor emotional health commonly co-occurs
with female sexual difficulties [1–3] and increases
the risk of developing a sexual dysfunction [4].
This large body of research highlights the impor-
tance of affective experiences in female sexual
functioning. As much of the current literature has
focused on sexual difficulties in the context of psy-
chiatric illnesses, an abundance of the extant evi-
dence has focused on clinical conditions, such as
depression and anxiety, as precipitating and per-
petuating factors of sexual dysfunction [1,5], much
to the exclusion of more normative affect states.
Yet, to better understand the psychogenic influ-
ences of female sexual response and dysfunction, it
is important to examine how normative affective
experiences correspond to sexual function in
women’s daily lives. As mood and anxiety disorders
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are, at least in part, the product of chronically and
severely dysregulated emotion, examining the
interplay between normative affect and sexual
response may not only offer insight into the spe-
cific affect states relevant to sexual response but
also improve our understanding of how normative
affect and sexual functioning coevolve into more
clinically significant states or disorders. To address
this gap, the present study employed a repeated
measures design to examine the relations of
normal variations in daily affect (i.e., joviality, self-
assurance, serenity, sadness, fear, and hostility) and
indices of sexual function (i.e., desire, subjective
arousal, lubrication, orgasmic function, and sexual
pain) in a sample of young women.
Normative affect, as opposed to clinical mood
or anxiety disorders, refers to normal, “everyday”
emotions, such as happiness and fear [6], which
change in response to our daily experiences. Nor-
mative affect states are less stable and severe than
pathological mood states. To illustrate, a person
may occasionally feel sad or fearful, but not suffer
from a mood or anxiety disorder. Affect consists of
both positive and negative states. Positive affect
refers to the degree to which a person feels happy,
enthusiastic, or confident, whereas negative affect
refers to an individual’s feelings of distress and
unpleasantness, including sadness, fear, and anger
[7,8]. Although affect includes both positive and
negative states, these experiences do not constitute
opposite ends of a continuum. Rather, positive and
negative affects are related, yet unique, constructs
[6–9] shown to be differently related to mood and
anxiety disorders such that low positive affect (i.e.,
anhedonia) is unique to depression, whereas high
negative affect is characteristic of both depression
and anxiety [10]. Moreover, positive and negative
affects have been shown to be independently
related to a number of health outcomes, including
sleep disturbance [11] and cardiovascular, gastro-
intestinal, and immunological health [12,13].
Although much of the research on emotional
health and sexual function has focused on sexual
problems in the context of psychopathology (e.g.,
Laurent and Simons, and Atlantis and Sullivan
[1,5]), recent investigations have shifted some of
the attention to the influence of positive and nega-
tive trait affects. Oliveira and Nobre [2] found that
both positive and negative trait affects constituted
vulnerabilities to overall sexual dysfunction, which
was partially mediated by depressed and anxious
mood states. In focusing on female sexual desire,
Peixoto and Nobre [3] similarly found that both
positive and negative trait affects constituted vul-
nerabilities to difficulties with female sexual desire
and that depressed mood partially mediated these
relations.
Despite this recently growing body of research,
a number of gaps exist in our understanding of the
transactional processes between affect and sexual
function. Notably, past investigations have placed
greater emphasis on interindividual differences
(trait) rather than intraindividual change (state).
Oliveira and Nobre’s [2] and Peixoto and Nobre’s
[3] showed that women with lower trait positive
affect and higher trait negative affect also reported
greater sexual dysfunction and lower desire com-
pared with women with high-trait positive mood
and low-trait negative mood. While these finding
are important in identifying interindividual vul-
nerabilities to sexual dysfunction, these investiga-
tions fail to account for the intraindividual
variance in the relation between affective experi-
ences and sexual function across time.
A number of studies have shown changes in
female sexual response following induced positive
and negative affects. Evidence suggests induced
positive affect allows for higher levels of desire [14]
and subjective arousal [15,16] in response to erotic
stimuli, although other evidence has not supported
relations between positive affect and arousal or
genital response [15,17]. In comparison, the rela-
tion between negative affect and female sexual
response is even more mixed. A number of experi-
mental studies have shown that induced negative
affect is related to greater levels of genital response
to erotic stimuli, but is unrelated to subjective
arousal [14,18]. These findings are intriguing as
they are not consistent with evidence supporting
relations between trait negative affect, depression,
anxiety, and poorer overall female sexual response
[1,2]. However, it is worth noting that, though a
useful manipulation in research, inducing affect in
the laboratory can be problematic [19,20] and may
suffer from poor ecological validity.
Experience sampling techniques are needed to
capture the dynamic interplay between affect and
sexual response while maximizing ecological valid-
ity. Additionally, repeated assessments of affect
and sexual function allow for the analysis of
intraindividual changes (i.e., state-level relations).
Much of the prior research on affect and sexual
function has used global measures of positive and
negative affects. Thus, it remains unclear which
specific affect states facilitate these associations.
Finally, a number of prior studies examined posi-
tive and negative affects separately, rendering it
impossible to examine the shared and independent
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effects of positive and negative affects on sexual
function. A more nuanced depiction afforded by
testing specific affect states and exercising greater
statistical control would allow for a clearer under-
standing of how these constructs are related.
Aims
The present investigation was a 2-week prospective
study following a sample of young adult women to
characterize the manner in which daily experiences
of positive (i.e., joviality, self-assurance, and seren-
ity) and negative affects (i.e., fear, sadness, and
anger) related to variations in sexual desire, subjec-
tive arousal, vaginal lubrication, orgasmic function,
and sexual pain. As the sample was nonclinical, our
data likely represent normal variations in affect
states and sexual function as compared with those
found in a psychiatric sample. To reduce potential
confounds, we accounted for the influence of age
and baseline severity of sexual distress, depression,
and anxiety. Additionally, as changes in sexual activ-
ity [21] and desire [22] have been associated with
the menstrual cycle, the presence of menstruation
was also examined as a possible confound. By using
repeated assessments, we aimed to capture day-to-
day variations in affect and sexual function and
improve ecological validity, while minimizing the
effects of recall bias.
Based on findings of past research on affective
symptoms and sexual response [23,24], we pre-
dicted that positive affect states would be more
consistently related to overall female sexual func-
tion, particularly sexual desire. This is based on
previous findings showing that depression-specific
anhedonia symptoms are related to greater sexual
difficulties and are consistently related to state and
trait desire [23,24]. We predicted that negative
affect states would be more consistently related to
vaginal lubrication, orgasmic function, and sexual
pain. A previous study of state relations between
affective symptoms and sexual response provided
greater support for concurrent, rather than tem-
poral, relations [23]. Thus, we predicted that the




One hundred and seventy-one women (age:
20.07 ± 3.32, range: 18–56) were assessed for a
period of 14 days. The sample was mostly Cauca-
sian (81.5%), although some ethnic diversity was
observed (13.3% African American, 1.2% Latino
or Hispanic, 2.3% Eastern Asian or Pacific
Islander, and 1.8% “Other”). Approximately 51%
of the sample reported having a significant other.
Of these relationships, the average length was
20.71 months (±18.56). Further, 56% of partici-
pants reported having at least one sexual partner at
baseline. Of these individuals, 92 women had one
sexual partner, two participants had two sexual
partners, and one participant had three sexual
partners. Participants were recruited from psy-
chology courses at a midwestern university and
received course credit for their participation.
Inclusion criteria were reliable Internet access and
being free of antidepressants for at least the 4
weeks prior to participation. The local institu-
tional review board approved this study. All
women provided written informed consent prior
to participation.
Procedure
The study protocol involved a baseline assessment,
followed by 14 daily assessments. At baseline, par-
ticipants reported demographic information and
symptoms of sexual distress, depression, and
anxiety over the past month, and then received
guidance on how to complete the daily, web-
delivered questionnaires. Participants were
instructed to complete all daily assessments on their
home computer upon waking each morning at their
habitual wake time. Questionnaires assessed affect
and sexual function over the previous 24 hours.
Baseline Measures
The Center for Epidemiologic Studies Depression
Scale (CESD) [25] is a 20-item self-report inven-
tory used to assess symptoms of depression. It was
modified to assess these symptoms over the past
month. Items were scored on a Likert-type scale
(0–3). Scores on the CESD range from 0 to 60. In
the present sample, the CESD achieved high
internal consistency (α = 0.90).
State-Trait Anxiety Inventory Form X–State
(STAIXS) [26] is a 20-item self-report inventory
intended to assess levels of anxiety. It was modified
to assess these symptoms over the past month.
Participants indicated their anxiety symptoms on a
Likert-type scale (1–4). Possible scores on the
STAIXS range from 20 to 80. Internal consistency
of the STAIXS was high (α = 0.94) in the present
sample.
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The Female Sexual Distress Scale-Revised
(FSDS-R) [27] is a 13-item self-report question-
naire used to assess sex-related personal distress in
women. In the present study, respondents indi-
cated the extent to which they experienced sexual
distress over the past month on a 1–6 Likert-type
response scale, with higher scores indicating
higher levels of sexual distress. Internal consis-
tency in our sample was adequate (α = 0.74).
Main Outcome Measures
Daily Measures
The Positive and Negative Affect Schedule-
Expanded form (PANAS-X) [28] is a self-report
measure that assesses various types of positive and
negative affect states. To minimize the time
demand of the daily assessments, administration of
the PANAS-X was limited to six subscales. Positive
affect: joviality (e.g., happy), self-assurance (e.g.,
proud), and serenity (e.g., calm). Negative affect:
fear (e.g., afraid), sadness (i.e., sad), and hostility
(i.e., angry). The six scales were chosen as they
were hypothesized to be most closely related to
sexual functioning, although this hypothesis was
largely exploratory. All subscales were modified to
assess daily levels of affect. Participants rated these
feelings on a five-point Likert-type scale (1–5). See
Table 1 for descriptives.
The Profile of Female Sexual Functioning
(PFSF) [29,30] is self-report measure of sexual
functioning that was modified for daily use in the
present study and has been validated for use in
nonclinical samples [31]. For the present study,
women reported their sexual desire, subjective
sexual arousal, and orgasmic function over the pre-
vious 24 hours. Scales consist of items on a 1–6
Likert-type response scale. Each scale was scored
using raw scores with higher scores indicating
better sexual function. Items specific to sexual
activity were provided with the response choice of
“No Sexual Activity,”1 which was based on Meyer-
Bahlburg and Dolezal’s critique of Female Sexual
Function Index (FSFI) scoring procedures [32].
See Table 1 for descriptives.
The FSFI [33] is a 19-item self-report measure
of sexual functioning that was modified for daily
use and has been validated for use in normative
samples [31,34,35]. To both avoid construct
overlap with the PFSF and to minimize time
demand of daily assessments on participants, only
the lubrication and pain scales were administered.
Both scales consisted of items asking about expe-
riences with sexual function of the previous 24
hours, and scales consisted of items scored on a
1–5 Likert-type response scale. In the present
study, each scale was scored using raw scores, with
higher scores on the lubrication scale indicating
better sexual functioning and higher scores on the
pain scale indicating higher levels of vaginal
pain. Based on the recommendations of Meyer-
Bahlburg and Dolezal [32], FSFI items were
1These responses were treated as missing data. For indi-
viduals who had less than 25% missing data in a given scale,
proration using participants’ mean scores (within that same
scale) was used to estimate total factor scores. However,
individuals’ scale scores were treated as missing if more
than 25% of data in a factor were missing. The rationale
was that treating a response of “No Sexual Activity” as zero
would artificially bias scores into indicating higher dys-
function, whereas proration allows us to estimate the total
scale score based on their other responses in the same scale.
However, we decided to only prorate when the response
rate was 75% and above as to minimize the impact of our
estimation on the data.
Table 1 Descriptive statistics and zero-order correlations between affect states and sexual function indices
Factor M ± SD, range α Serenity Self-assurance Fear Sadness Hostility
Desire 24.71 ± 10.45, 9–54 0.94 0.15 0.20 −0.02 −0.05 −0.00
Arousal 17.19 ± 2.15, 3–18 0.99 0.05 −0.00 −0.27 −0.24 −0.21
Lubrication 18.57 ± 2.55, 4–20 0.96 0.05 0.01 −0.12 −0.09 −0.13
Orgasm 20.46 ± 3.93, 4–24 0.97 0.12 0.10 −0.34 −0.33 −0.19
Pain 5.21 ± 2.56, 4–20 0.99 −0.18 −0.01 0.22 0.20 0.15
Joviality 11.51 ± 4.39, 4–20 0.95 0.64 0.82 −0.20 −0.32 −0.27
Serenity 5.30 ± 2.20, 2–10 0.92 — 0.61 −0.26 −0.27 −0.27
Self-assurance 12.92 ± 5.35, 5–25 0.92 — — −0.15 −0.24 −0.21
Fear 7.63 ± 2.77, 6–30 0.86 — — — 0.55 0.48
Sadness 5.50 ± 2.53, 4–20 0.84 — — — — 0.53
Hostility 4.35 ± 2.06, 3–15 0.82 — — — — —
Desire, arousal, and orgasm measured using the Profile of Female Sexual Function. Lubrication and pain measured using the Female Sexual Function Index.
Joviality, serenity, self-assurance, fear, sadness, and hostility measured using the Positive and Negative Affect Schedule. Significance values are not reported as
these correlations are for descriptive purposes only
M = mean; SD = standard deviation
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presented with a “No Sexual Activity” response
option.1 See Table 1 for descriptives.
To measure the presence of menstruation, par-
ticipants were asked each day “Have you menstru-
ated over the past 24 hours?” and responded either
“Yes” (coded as 1) or “No” (coded as 2).
Data Analysis
The data collected involved repeated assessments.
To account for the time-nested structure of the
data, analyses were conducted using hierarchical
linear modeling (HLM; also known as multilevel
modeling). HLM allows for the simultaneous
examination of interindividual differences and
intraindividual change. As such, this analytic
approach can test: the predictive qualities of base-
line reports of sexual distress, depression, and
anxiety on later sexual function; same-day associa-
tions between affect and sexual response; and bidi-
rectional temporal precedence of daily affect and
sexual function. Importantly, HLM is robust to
missing data, which are common in repeated mea-
sures studies [36]. HLM uses full information
maximum likelihood (FIML) as a means of estima-
tion. FIML is widely accepted as a superior
method of addressing missing data and producing
maximally unbiased results [37,38]. Rather than
imputing missing values, FIML uses only available
data to provide estimation [37]. Thus, the HLM
models’ estimates for indices reflecting sexual
activity (i.e., arousal, genital response, pain, orgas-
mic function) were based on data from days during
which sexual activity occurred. That is, estimates
were based on data from women who engaged in
sexual activity and only on days they engaged in
sexual activity. As such, missing data due to not
having an available sexual partner (as indicated at
baseline) or due to choosing not to engage in
sexual activity on a certain day would not affect the
relations between affect and sexual response.2
Preliminary Analyses
To examine the impact of baseline characteristics
on female sexual function (for individual i at time
t), each outcome variable was predicted by baseline
sexual distress, depression, and anxiety (for indi-
vidual i), controlling for daily presence of men-
struation (for individual i at time t) and age (for
individual i). These analyses were conducted to
determine which variables to use as covariates in
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Equation 1 revealed differences in sexual func-
tion outcomes for women with varying baseline
severity of depression, anxiety, and sexual distress.
Additionally, this model revealed any influence of
menstruation as well as age effects on sexual func-
tion in the sample. Subsequent analyses included
significant predictors as covariates to allow for the
testing of relations between daily affect and sexual
function independent of higher order symptoms of
anxiety and depression, sexual distress, age effects,
and impact of daily menstruation.
Substantive Hypotheses
To examine intraindividual relations between daily
affect and female sexual function, we first regressed
sexual function onto the same day’s affect states


























Next, to examine temporal relations, we regressed
sexual function onto the previous day’s affect states
while controlling for relevant covariates and
the lagged value of the outcome variable. By
controlling for the previous day’s outcome variable
(i.e., at time t − 1), any significant relations
between affect at time t − 1 and sexual function at
time t was independent of the impact of the
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In examining sexual function’s impact on the
following day’s affective experience, analyses were
2Analyses revealed that including baseline partner availabil-
ity as a covariate in the HLM models did not influence any
of the relations between affect and sexual response.
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run in the same manner that the lagged relations in
the opposite direction were conducted.
Results
Preliminary Analyses
According to the FSDS-R,3 19.30% of women in
the present study indicated clinically significant
levels of sexual distress (19.81 ± 11.24). Regarding
depression and anxiety, 3% of participants
reported clinically significant levels of baseline
depression (CESD: 13.37 ± 9.78) [39], whereas
9% of participants indicated clinical levels of
anxiety (STAIXS: 41.92 ± 10.98) [40]. See Table 1
for bivariate correlations between affect states and
sexual function indices, which we present for
descriptive purposes to orient the reader to the
data. Regarding sexual activity, women reported
self-stimulation on 8.90% of days and sexual activ-
ity with a partner on 15.46% of days.
Concurrent Models
Desire
We first ran a null model with sexual desire
regressed on an intercept, a Level-1 (intraindi-
vidual) residual, and a Level-2 (interindividual)
residual. Results indicated that approximately 54%
of the total variance in sexual desire was due
to intraindividual fluctuations. Thus, the data
revealed marked variations in day-to-day levels of
desire to justify the examination of time-varying
outcomes. Next, we fit a multilevel model estimat-
ing sexual desire as predicted by menstruation, age,
and baseline anxiety, depression, and sexual distress
(see Table 2). Analyses revealed that women expe-
rienced greater sexual desire when they were not
menstruating (P < 0.01). None of the baseline
3Unlike the original 0–4 scale, the present study adminis-
tered the FSDS-R using a 1–6 scale. As such, a clinical
cutoff of 27 (calculated to be most parallel to the 11-point
cutoff) was used to adjust for the scaling difference.
Table 2 Same-day and temporal relations regressing sexual desire on affect
Outcome Predictor Β z P value Chi-square P value
Determining covariates
Desireit Level 1 14.31 0.01
Intercept 28.07 6.65 <0.001
Menstruationit 1.64 3.03 <0.01
Level 2
Anxietyi −0.05 −0.56 0.58
Depressioni −0.06 −0.70 0.49
Sexual distressi 0.10 1.84 0.07
Age −0.22 1.36 0.18
Concurrent model
Desireit Level 1 184.76 <0.001
Intercept 12.89 7.45 <0.001
Jovialityit 0.61 6.90 <0.001
Self-assuranceit 0.08 0.94 0.35
Serenityit 0.21 1.59 0.11
Fearit −0.09 −1.01 0.31
Sadnessit 0.12 1.08 0.28
Hostilityit −0.10 −0.79 0.43
Menstruationit 1.71 3.26 <0.001
Lagged model
Desireit Level 1 62.30 <0.001
Intercept 16.58 8.79 <0.001
Jovialityit−1 0.27 2.77 <0.01
Self-assuranceit−1 −0.07 −0.80 0.43
Serenityit−1 0.12 −0.80 0.43
Fearit−1 0.19 1.84 0.07
Sadnessit−1 −0.08 −0.70 0.49
Hostilityit−1 −0.14 −1.03 0.30
Menstruationit 1.72 2.90 <0.01
Desireit−1 0.12 4.96 <0.001
N = 171; observations = 2,144
In multilevel modeling, the chi-square statistic reflects the difference between the tested model and a null model with no predictors. Thus, a significant chi-square
is desirable, as it is indicative of a model that accounts for significant variance in the outcome. This is in contrast to the use of chi-square in structural equation
modeling, in which significant chi-square statistics are undesirable and reflect a lack of model fit. Β = unstandardized beta coefficient. z-Scores represent testing
the predictor’s significance
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predictors were significant. As such, menstruation
was included as a covariate in all subsequent models
in which sexual desire was the outcome variable.
We then examined how daily affect related to
concurrent sexual desire, controlling for menstrua-
tion (see Table 2). Analyses revealed that women
experienced greater sexual desire when they were
more jovial (P < 0.001). No other affect state was
independently related to concurrent sexual desire.
Menstruation remained a significant predictor such
that women experienced greater desire when they
were not menstruating (P < 0.001).
Subjective Arousal
The null model indicated that approximately 44%
of the total variance in subjective arousal was
due to intraindividual variation. Next, analyses
revealed that older women (P = 0.02) and women
reporting greater sexual distress (P < 0.01) experi-
enced lower levels of arousal (see Table 3). We
then examined how daily affect predicted subjec-
tive arousal, controlling for age and sexual distress.
Analyses revealed that women experienced
lower levels of arousal when they were more
fearful (P < 0.001) and self-assured (P = 0.03). No
other affect state was related to concurrent
sexual arousal. Sexual distress (P = 0.01) and age
(P < 0.01) remained significant predictors. Finding
that fear and self-assurance were similarly related
to sexual arousal was contradictory. Further, the
direction of this relation between self-assurance
and arousal was not consistent with the descriptive
bivariate correlation. Given the large number of
predictors and collinearity between affect states,
poor estimation of the beta weight was considered.
As such, a model regressing subjective arousal only
on same-day fear and self-assurance was run to
explore this possibility. In this model, higher levels
of fear remained related to poorer arousal
(β = −0.23, z = −6.66, P < 0.001), whereas self-
assurance became nonsignificant (β = −0.02,
z = −0.12, P = 0.22). Thus, the earlier finding that
Table 3 Same-day and temporal relations regressing subjective arousal on affect
Outcome Predictor Β z P value Chi-square P value
Determining covariates
Arousalit Level 1 19.53 <0.01
Intercept 20.81 16.27 <0.001
Menstruationit −0.27 −1.21 0.23
Level 2
Anxietyi −0.01 0.30 0.76
Depressioni 0.01 0.34 0.73
Sexual distressi −0.06 −2.79 <0.01
Agei −0.12 −2.33 0.02
Concurrent model
Arousalit Level 1 68.63 <0.001
Intercept 22.42 20.98 <0.001
Jovialityit 0.05 1.53 0.13
Self-assuranceit −0.06 −2.12 0.03*
Serenityit −0.04 −0.78 0.44
Fearit −0.21 −5.59 <0.001
Sadnessit −0.05 −1.10 0.27
Hostilityit 0.00 0.05 0.96
Level 2
Sexual distressi −0.04 −2.50 0.01
Agei −0.12 −2.64 <0.01
Lagged model
Arousalit Level 1 34.98 <0.001
Intercept 15.23 7.75 <0.001
Jovialityit−1 −0.05 −1.08 0.28
Self-assuranceit−1 0.03 0.80 0.42
Serenityit−1 0.03 0.45 0.66
Fearit−1 −0.02 −0.31 0.76
Sadnessit−1 0.05 0.60 0.55
Hostilityit−1 −0.09 −1.13 0.26
Arousalit−1 0.23 3.75 <0.001
Level 2
Sexual distressi −0.03 −2.28 0.02
Agei −0.05 −0.79 0.43
n = 140; observations = 571
*Erroneous significant relation due to poor beta estimation as determined by follow-up analyses
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self-assurance was related to lower arousal was
likely attributable to a type III error, resulting
from a bouncing beta.
Vaginal Lubrication
The null model indicated that intraindividual
variation accounted for approximately 48% of the
total variance in vaginal lubrication. Next, analyses
revealed that older women reported lower levels of
vaginal lubrication (P < 0.01; see Table 4). We
then examined how daily affect predicted lubrica-
tion, controlling for age. Analyses revealed that
women experienced poorer vaginal lubrication
when they were more fearful (P < 0.01). No other
affect state was significant. Age remained a signifi-
cant predictor (P < 0.01).
Orgasmic Function
The null model indicated that intraindividual
changes accounted for approximately 43% of the
total variance in orgasmic function. Next, analyses
revealed that older women (P = 0.02) and women
with greater sexual distress (P < 0.05) reported
poorer orgasmic function (see Table 5). We then
examined how daily affect predicted orgasmic
function, controlling for age and sexual distress.
Analyses revealed that women experienced poorer
orgasmic function when they were more fearful
(P < 0.001). No other affect state was significant.
Age (P = 0.01) and sexual distress (P = 0.02)
remained significant predictors.
Vaginal Pain
The null model indicated that intraindividual
variation accounted for approximately 46% of the
total variance in vaginal pain. Next, analyses
revealed that women with greater baseline sexual
distress experienced greater vaginal pain (P = 0.02;
see Table 6). We then examined how daily affect
predicted pain, controlling for sexual distress.
Analyses revealed that women experienced greater
vaginal pain when they were more fearful
(P = 0.05). No other affect state was significant.
Baseline sexual distress remained a significant pre-
dictor of vaginal pain (P = 0.02).
Table 4 Same-day and temporal relations regressing vaginal lubrication on affect
Outcome Predictor Β z P value Chi-square P value
Determining covariates
Lubricationit Level 1 15.09 0.01
Intercept 23.20 15.13 <0.001
Menstruationit −0.32 −0.89 0.37
Level 2
Anxietyi −0.01 −0.46 0.65
Depressioni 0.01 0.34 0.73
Sexual distressi −0.03 −1.64 0.10
Agei −0.16 −2.96 <0.01
Concurrent model
Lubricationit Level 1 25.36 <0.001
Intercept 23.38 18.55 <0.001
Jovialityit 0.04 0.95 0.34
Self-assuranceit −0.05 −1.23 0.22
Serenityit 0.01 0.13 0.90
Fearit −0.14 −2.78 <0.01
Sadnessit −0.00 −0.05 0.96
Hostilityit −0.04 −0.62 0.53
Level 2
Agei −0.17 −3.36 <0.01
Lagged model
Lubricationit Level 1 14.85 0.06
Intercept 13.89 4.71 <0.001
Jovialityit−1 0.11 1.47 0.14
Self-assuranceit−1 −0.06 −1.06 0.29
Serenityit−1 0.04 0.45 0.65
Fearit−1 −0.04 −0.42 0.68
Sadnessit−1 0.12 0.83 0.41
Hostilityit−1 0.08 0.67 0.50
Lubricationit−1 0.24 3.02 <0.01
Level 2
Agei −0.05 −0.41 0.68
n = 136; observations = 476
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Temporal Relations
Regressing Sexual Function on
Previous-Day Affect
In examining temporal relations between affect
and female sexual function, we first regressed
indices of sexual functioning onto the previous
day’s affect states while controlling for the previ-
ously identified covariates and the outcome vari-
able’s lagged value (see Tables 2–6). Overall, fewer
temporal effects were found. Specifically, we found
that greater joviality predicted higher levels of
next-day sexual desire (P < 0.01; Table 2). To test
whether the predictive abilities of joviality on next-
day desire were mediated through sexual activity,
we estimated the confidence interval (CI) for the
indirect effect between joviality and next-day
desire, as mediated by sexual activity (a dichoto-
mous variable) using steps outlined by Tofighi and
MacKinnon [41]. When regressing desire on
sexual activity (β = 14.04, z = 29.72, P < 0.001)
and previous-day joviality (β = 0.17, z = 3.75,
P < 0.001), both predictors were significant. The
indirect effect of sexual activity mediating the asso-
ciation between joviality and next-day desire was
estimated to be 3.93 (standard error [SE] = 0.85),
and examination of the confidence interval (95%
CI = 2.271–5.616) indicated that mediation was
statistically significant. Other analyses indicated
that subjective sexual arousal, vaginal lubrication,
orgasmic function, and sexual pain were not pre-
dicted by any previous-day affect states.
Regressing Affect on Previous-Day
Sexual Function
Models regressing affect on previous-day sexual
functioning were conducted in the same manner as
the previously described models (see Table 7).
Null models indicated that 40–53% of the variance
in the affect states were due to intraindividual
change. Predicting serenity, analyses revealed that
greater sexual desire predicted greater next-day
serenity while controlling for baseline anxiety. As
this relation was not found in the concurrent
model, we ran an additional model regressing
Table 5 Same-day and temporal relations regressing orgasmic function on affect
Outcome Predictor Β z P value Chi-square P value
Determining covariates
Orgasmit Level 1 17.16 <0.01
Intercept 26.57 11.41 <0.001
Menstruationit −0.06 −0.14 0.89
Level 2
Anxietyi 0.02 0.36 0.72
Depressioni −0.06 −1.12 0.26
Sexual distressi −0.07 −1.99 <0.05
Agei −0.20 −2.36 0.02
Concurrent model
Orgasmit Level 1 38.13 <0.001
Intercept 26.90 13.98 <0.001
Jovialityit −0.00 −0.00 1.00
Self-assuranceit 0.02 0.39 0.70
Serenityit −0.01 −0.12 0.90
Fearit −0.28 −3.88 <0.001
Sadnessit −0.09 −0.89 0.37
Hostilityit 0.09 0.89 0.37
Level 2
Sexual distressi −0.06 −2.38 0.02
Agei −0.20 −2.48 0.01
Lagged model
Orgasmit Level 1 40.37 <0.001
Intercept 18.03 5.25 <0.001
Jovialityit−1 0.01 0.15 0.88
Self-assuranceit−1 0.08 1.10 0.27
Serenityit−1 −0.19 −1.53 0.13
Fearit−1 −0.05 −0.51 0.61
Sadnessit−1 −0.16 −1.16 0.25
Hostilityit−1 0.12 0.83 0.40
Orgasmit−1 0.34 4.90 <0.001
Level 2
Sexual distressi −0.00 −0.15 0.88
Agei −0.20 −1.46 0.14
n = 136; observations = 520
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serenity on only the previous day’s desire (β = 0.02,
z = 3.99, P < 0.001), which was significant and thus
suggested this finding was not likely to be errone-
ous. To test whether the predictive abilities of
sexual desire on next-day serenity were mediated
through sexual activity, we estimated the confi-
dence interval for the indirect effect between
desire and serenity, mediated by sexual activity.
When regressing serenity onto sexual activity
(β = 0.02, z = 3.99, P < 0.001) and previous-day
desire (β = 0.34, z = 3.21, P < 0.01), both predic-
tors were significant. Further, the indirect effect
estimate was 0.007 (SE = 0.003), and examination
of the confidence interval (95% CI = 0.002–0.012)
indicated that mediation was statistically signifi-
cant. This finding suggested that sexual desire
does predict next-day serenity but that this rela-
tion was partially mediated by sexual activity,
though the size of the indirect effect is modest.
The next significant relation revealing sexual
function predicting next-day affect indicated that
greater desire was related to greater next-day fear.
This finding was inconsistent with the descriptive
bivariate correlation and the covariance model.
Thus, concern for a type III error was considered.
We then regressed fear only on the previous day’s
sexual desire (β = −0.01, z = −1.34, P = 0.18),
which revealed that desire did not predict next-day
fear. As such, the finding was interpreted as a type
III error due to poor beta estimation. We also
found that better orgasmic function predicted less
next-day sadness, whereas better lubrication pre-
dicted greater next-day sadness. However, as
neither of these relations was found in the covari-
ance model, we wanted to rule out erroneous sig-
nificant findings. Thus, we regressed sadness on
the previous day’s vaginal lubrication and orgas-
mic function without any other predictors in sepa-
rate models. The first model indicated that
lubrication (β = −0.04, z = −0.99, P = 0.32) did not
predict next-day sadness. As such, this finding was
identified as a multicollinearity artifact. In con-
trast, regressing sadness on the previous day’s
orgasmic function showed that better orgasmic
functioning predicted low levels of sadness the fol-
lowing day (P = 0.03). We then re-ran the model
regressing sadness on previous-day orgasmic func-
tion and the lagged outcome value and found that
Table 6 Same-day and temporal relations regressing vaginal pain on affect
Outcome Predictor Β z P value Chi-square P value
Determining covariates
Painit Level 1 12.53 <0.001
Intercept 2.30 1.46 0.15
Menstruationit 0.42 1.16 0.25
Level 2
Anxietyi 0.05 1.72 0.09
Depressioni −0.04 −1.12 0.26
Sexual distressi 0.04 1.94 0.05
Agei 0.02 0.42 0.67
Concurrent model
Painit Level 1 17.59 0.01
Intercept 3.63 4.68 <0.001
Jovialityit 0.02 0.44 0.66
Self-assuranceit 0.02 0.48 0.63
Serenityit −0.10 −1.49 0.14
Fearit 0.11 1.96 0.05
Sadnessit 0.05 0.74 0.46
Hostilityit −0.04 −0.61 0.54
Level 2
Sexual distressi 0.04 2.26 0.02
Lagged model
Painit Level 1 83.07 <0.001
Intercept 2.38 2.15 0.03
Jovialityit−1 −0.04 −0.60 0.55
Self-assuranceit−1 0.03 0.62 0.54
Serenityit−1 −0.11 −1.23 0.22
Fearit−1 −0.08 −0.91 0.36
Sadnessit−1 0.15 1.00 0.32
Hostilityit−1 −0.04 −0.34 0.73
Painit−1 0.64 8.16 <0.001
Level 2
Sexual distressi 0.01 0.42 0.67
n = 130; observations = 442
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Table 7 Temporal relations regressing affect on previous-day sexual function
Outcome Predictor Β z P value Chi-square P value
Jovialityit Level 1 68.17 <0.001
Intercept 19.48 11.13 <0.001
Menstruationit −0.08 −0.43 0.67
Level 2
Anxietyi −0.09 −2.65 0.09
Depressioni −0.12 −3.12 <0.01
Sexual distressi 0.02 0.96 0.34
Agei −0.03 −0.46 0.64
Jovialityit Level 1 120.96 <0.001
Intercept 12.36 5.22 <0.001
Desireit−1 0.03 1.08 0.28
Arousalit−1 −0.20 −1.60 0.11
Lubricationit−1 0.02 0.16 0.87
Orgasmit−1 0.03 0.48 0.63
Painit−1 −0.12 −1.34 0.18
Jovialityit−1 0.40 7.32 <0.001
Level 2
Anxietyi −0.08 −2.21 0.03
Depressioni −0.01 −0.14 0.89
Self-assuranceit Level 1 50.86 <0.001
Menstruationit −0.18 −0.86 0.39
Level 2
Anxietyi −0.13 −2.81 <0.01
Depressioni −0.10 −1.96 0.05
Sexual distressi 0.01 0.44 0.66
Agei 0.03 0.29 0.77
Self-assuranceit Level 1 251.35 <0.001
Intercept 12.33 4.79 <0.001
Desireit−1 0.01 0.51 0.61
Arousalit−1 −0.11 −0.82 0.41
Lubricationit−1 −0.10 −0.96 0.34
Orgasmit−1 0.05 0.89 0.38
Painit−1 −0.16 −1.59 0.11
Self-assuranceit−1 0.55 11.59 <0.001
Level 2
Anxietyi −0.09 −2.42 0.02
Depressioni −0.01 −0.13 0.90
Serenityit Level 1 76.18 <0.001
Intercept 8.46 9.89 <0.001
Menstruationit 0.01 0.11 0.91
Level 2
Anxietyi −0.07 −4.31 <0.001
Depressioni −0.02 −1.13 0.26
Sexual distressi −0.00 −0.27 0.79
Agei 0.03 0.79 0.43
Serenityit Level 1 129.36 <0.001
Intercept 7.41 6.14 <0.001
Desireit−1 0.03 2.20 0.03
Arousalit−1 −0.10 −1.58 0.11
Lubricationit−1 0.01 0.21 0.83
Orgasmit−1 −0.03 −1.01 0.32
Painit−1 −0.05 −1.10 0.27
Self-assuranceit−1 0.34 6.78 <0.001
Level 2
Anxietyi −0.06 −4.95 <0.001
Fearit Level 1 84.66 <0.001
Intercept 3.48 3.46 <0.01
Menstruationit −0.14 −1.11 0.27
Level 2
Anxietyi 0.05 2.67 <0.01
Depressioni 0.07 3.50 <0.001
Sexual distressi −0.01 −0.45 0.65
Agei −0.00 −0.02 0.98
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better orgasmic function predicted a decrease in
sadness the following day (β = −0.06, z = −2.25,
P = 0.03).
Menstruation,Affect, and Sexual Function
In addition to the study’s primary aims, relations
between daily menstruation, affect, and sexual
function and activity were found. Women reported
lower desire when menstruating (P < 0.001; see
Table 2 concurrent model), whereas menstruation
was not related to arousal, lubrication, orgasmic
function, or sexual pain (see Tables 2–6). However,
multilevel logistical regression revealed that
women were more than twice as likely to abstain
from sexual activity when they were menstruating
(odds ratio = 2.68, β = 0.98, z = 3.91, P < 0.001).
Though, when examining menstruation’s influ-
ence on arousal, lubrication, orgasmic function,
and pain, we found that the average number of
observations per participant for each analysis
Table 7 Continued
Outcome Predictor Β z P value Chi-square P value
Fearit Level 1 93.95 <0.001
Intercept 2.01 1.61 0.11
Desireit−1 0.03 2.09 0.04*
Arousalit−1 0.06 0.89 0.38
Lubricationit−1 0.24 0.46 0.65
Orgasmit−1 −0.05 −1.70 0.09
Painit−1 −0.08 −1.55 0.12
Fearit−1 0.27 5.58 <0.001
Level 2
Anxietyi 0.01 0.69 0.49
Depressioni 0.05 2.13 0.03
Sadnessit Level 1 123.63 <0.001
Intercept 1.09 1.26 0.21
Menstruationit 0.06 0.53 0.60
Level 2
Anxietyi 0.02 1.12 0.26
Depressioni 0.11 6.29 <0.001
Sexual distressi −0.01 −0.87 0.39
Agei −0.00 −0.05 0.96
Sadnessit Level 1 127.19 <0.001
Intercept 2.38 2.37 0.02
Desireit−1 0.00 0.01 0.99
Arousalit−1 −0.08 −1.25 0.21
Lubricationit−1 0.10 2.18 0.03*
Orgasmit−1 −0.06 −2.39 0.02
Painit−1 −0.01 −0.21 0.83
Sadnessit−1 0.28 6.54 <0.001
Level 2
Depressioni 0.06 4.62 <0.001
Hostilityit Level 1 56.42 <0.001
Intercept 2.29 2.96 <0.01
Menstruationit −0.22 −2.12 0.03
Level 2
Anxietyi 0.04 2.75 <0.01
Depressioni 0.02 1.26 0.21
Sexual distressi 0.02 1.47 0.14
Agei −0.01 −0.31 0.76
Hostilityit Level 1 76.96 <0.001
Intercept 1.99 1.56 0.12
Desireit−1 0.01 0.60 0.55
Arousalit−1 −0.01 −0.23 0.82
Lubricationit−1 0.07 1.44 0.15
Orgasmit−1 −0.05 −1.70 0.09
Painit−1 −0.01 −0.25 0.81
Hostilityit−1 0.27 5.64 <0.001
Menstruationit −0.41 −1.26 0.21
Level 2
Anxietyi −0.01 −0.23 0.82
*Erroneous significant relation due to poor beta estimation as determined by follow-up analyses
n = 125; observations = 404–407
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ranged from 3.4 to 3.9 (i.e., indication that
although less likely, women did engage in sexual
activity on days they menstruated), it is possible
that the low number of observations per partici-
pant resulted in a lack of power to detect any
relations between menstruation and other indices
of sexual function. Regarding menstruation and
daily affect, women were more hostile when they
were menstruating (P = 0.03; see Table 7 covariate
model). No other relation between menstruation
and daily affect was observed.
Discussion
The present study used daily assessments over a
2-week period to examine changes in affect and
corresponding variation in female sexual function.
Evidence supported specificity between affect
states and indices of sexual function. Specifically,
we found joviality (i.e., happiness, enthusiasm)
and—to a lesser extent—serenity (i.e., feeling
calm and relaxed) to be uniquely related to sexual
desire, whereas fear was independently related to
same-day subjective arousal, lubrication, orgasmic
function, and vaginal pain. Finally, we found that
better orgasmic function predicted decreased
next-day sadness. Overall, these relations were
more concurrent than temporal and were robust
to the influences of daily menstruation, age
effects, and baseline sexual distress and affective
symptoms. Demonstrating that daily affect and
sexual function fluctuate together on a day-to-day
basis underlines the inextricability of emotional
and sexual health.
A greater number of concurrent relations
between daily affect and sexual function were found
than temporal relations in either direction. Regard-
ing positive affect, when women were happier, they
experienced greater sexual desire. No other con-
current relations were found between positive
affect and female sexual function indices. Regard-
ing negative affect, women experienced poorer sub-
jective arousal, vaginal lubrication, and orgasmic
function, as well as greater sexual pain, on days they
were more fearful.
Although relations between affect and sexual
function were more concurrent than temporal, a
small number of temporal relations were observed.
In the direction of affect predicting next-day
sexual function, we found that when women were
happier, they experienced greater sexual desire the
following day. Additional analysis indicated that
this relation was partially mediated by sexual activ-
ity such that when women were happy, they were
more likely to engage in sexual activity the next
day, which was related to greater feelings of sexual
desire. No other affect states predicted next-day
sexual function in the present study.
In the opposite direction, we found that when
women reported greater sexual desire, they expe-
rienced greater calmness the next day. Upon
further examination, results indicated that desire’s
impact on later serenity was partially mediated by
sexual activity. That is, not only did greater desire
directly lead to higher levels of calmness the fol-
lowing day but when women felt greater desire,
they engaged in sexual activity the following day,
which was associated with greater calmness and
relaxation. Additionally, results indicated that
better orgasmic functioning corresponded to
decreases in sadness the next day. It is unclear,
however, if the decreases in sadness were due to
better orgasmic functioning or if the relation was
driven primarily by the actual achievement of
orgasm during sexual activity.
Daily affect’s association with female sexual
function may shed light not only on the daily
transaction between affect and sexual function but
also on the presence of sexual difficulties in the
context of depressed or anxious mood. As depres-
sion and anxiety disorders are, at least in part, the
product of chronically and severely dysregulated
affect, intraindividual (i.e., state-level) relations
between affect and sexual function may offer
insight into the development of comorbid depres-
sion, anxiety, and female sexual dysfunction.
High negative affect (i.e., fear, sadness) has been
identified as being similarly related to both depres-
sion and anxiety [42,43]. In other words, sadness
and fear, in and of themselves, do not reliably
differentiate between the two disorders. As such,
finding that fear was consistently and robustly
related to same-day arousal, lubrication, orgasmic
function, and sexual pain may explain why both
depression and anxiety disorders have been simi-
larly linked to these indices of sexual function [1].
To illustrate, these findings indicate that the extent
to which women experience fear corresponds to
their capacity for arousal, ability to achieve
orgasm, and degree of sexual pain. Consistent with
a stress–diathesis model, symptoms of depression
and anxiety in response to a major life event may
manifest as chronic fear and worry, physical
tension, and self-isolation because of lack of moti-
vation and unhappiness. Along with these cogni-
tive, emotional, and somatic changes, diminished
subjective arousal and difficulty with genital
response and orgasm achievement are likely to be
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experienced. As increased severity and chronicity
of fear and general distress (i.e., shared symptoms
of depression and anxiety) [42] correspond to
simultaneous decreases in levels of arousal and
orgasmic function, as well as greater pain, our
findings describe how these changes in normative
affect and sexual response can coevolve into more
clinical states. In other words, it may not be that
negative affect or fear leads to co-occurring sexual
problems but that both are the result of the same
underlying processes. Notably, this interpretation
is consistent with recent conceptualizations
offered in the literature proposing that depression,
anxiety, and sexual dysfunction comprise related
forms of internal psychopathology [1,2,44].
However, it is difficult to overlook that it was
fear, but not sadness, that was uniquely related to
arousal indices, orgasmic function, and sexual pain.
Notably, activation of the autonomic nervous
system plays an important role in anxiety [45,46],
sexual arousal, and genital blood flow [47,48],
and some research has shown that anxiety-
specific symptoms (i.e., physiological arousal, e.g.,
increased heart rate, muscle tension) are related to
poorer lubrication and orgasmic function, and
greater vaginal pain [24]. Given the commonality of
somatic arousal to these aspects of mental and
sexual health, dysregulation of these systems may
constitute a shared risk or mediating factor between
fear or anxiety and these sexual difficulties. Thus,
one potential underlying mechanism that may drive
the relation between fear and sexual dysfunction
may be autonomic dysregulation. That is, as
an individual experiences greater physiological
hyperarousal, she may experience increases in both
fear and sexual difficulties, consistent with a coevo-
lution hypothesis. It may behoove future investiga-
tors to explore this possibility.
Additionally, as anhedonia is an affective
symptom unique to depression [42], our finding
that lower levels of happiness, enthusiasm, and
cheerfulness are related to same-day diminished
desire indicates that diminished desire is uniquely
related to depression-specific symptoms. Addition-
ally, results showing that lower joviality predicted
next-day decreases in desire may be suggestive of
depression-specific affect symptoms conferring a
vulnerability to diminished libido. These findings
are consistent with past research examining the
trait and state relations of anhedonia and female
sexual desire [23,24]. Similar to the previously pro-
vided example, our findings suggest that depression
and hypoactive desire symptoms may coevolve.
That is, a psychologically healthy individual who is
exposed to a stressor may experience simultaneous
reductions in happiness, enthusiasm, and interest in
sex. If these simultaneous changes develop into
clinical states, this coevolution may partially
account for the high comorbidity between depres-
sion and low levels of sexual desire. It would serve
future studies well to explore the mechanisms facili-
tating the relation between joviality (or lack thereof
in anhedonia) and sexual desire. For instance, a
number of studies have shown dopamine activity to
be related to a lack of pleasure and depression (see
Treadway and Zald [49] for review) and the neuro-
biology of sexual desire [47]. Taken together, it is
possible that depressed affect and hypoactive desire
share similar pathophysiology.
The findings of the present study should be
interpreted in the context of certain limitations.
Notably, the present study’s sample consisted of
young women who were less likely to be encum-
bered by medical illnesses or severe mental health
disorders as compared with older or clinical
samples. Even so, women in the present study were
not screened for other psychological or medical
issues or medications that could potentially impact
these findings. As such, future studies are necessary
to determine whether these results generalize to
older women or individuals with clinical affective or
sexual disorders. Furthermore, examination of
these relations is needed in men, as the specificity
between affect and sexual function in men may not
mirror the relations found in women. Regarding
our measure of affect, the present study used six
affect scales in examining positive and negative
affects, which do not fully capture all dimensions of
positive and negative affects. Additionally, the
degree of balance between positive and negative
affects has been shown to be important to sexual
response [50]. Thus, future investigations may con-
sider examining how variations in the degree of
balance between positive and negative affects cor-
respond to changes in sexual function.
An additional limitation regards statistical
power. Although the study benefited from a large
sample and number of observations, two study
characteristics threatened power to detect effects.
First, our sample was relatively healthy in regard
to emotional and sexual health. Thus, range
restriction of target variables may have hindered
the ability to detect relations. Indeed, daily nega-
tive affect and sexual function (excluding desire)
indices’ means and standard deviations reveal a
floor and ceiling effects (see Table 1). Secondly,
given the large number of correlated predictors in
the HLM models, collinearity and overdeter-
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mination were threats to power and beta estima-
tion. Further, specific to the temporal models,
lagged outcome values were entered as covariates.
Outcome variables and their lagged values are
highly related and are likely to be related to the
same stochastic parts. Although we believe that
controlling for these covariates was important for
ruling out potential confounds and that entering
each of the six affect states in a single model (rather
than in individual models) to decrease the risk for
type I error was important, these statistical deci-
sions likely increased the risk of type II, and even
type III, errors.
Despite these limitations, the present study also
offers a number of clinical implications for indi-
viduals presenting with sexual problems thought
to be largely psychogenic or in the context of
depression or anxiety. Namely, the results are con-
sistent with prior investigations indicating that
women presenting with a dysfunctional balance of
positive and negative affects (i.e., low positive
affect relative to high positive–negative affect) are
vulnerable to sexual dysfunction and distress
[50,51]. As such, women with these low positive
and high negative affect profiles may experience
poorer treatment response to pharmacologic
and psychological interventions as compared to
women with more evenly balanced or positive
affect profiles. However, this knowledge may help
inform treatment planning. For women presenting
with a primary complaint of diminished sexual
desire, increasing positive affect may be therapeu-
tic and enhance capacity for sexual desire. Con-
versely, it may be that placing greater emphasis on
reducing fear may better target primary com-
plaints regarding arousal, orgasm, or pain difficul-
ties that present with psychological perpetuating
factors. As fear was concurrently related to these
aspects of female sexual function, then techniques
to decrease both affective and somatic tension,
such as progressive muscle relaxation or mindful-
ness exercises, may be useful skills to teach women
with these complaints. Recent research has shown
muscle relaxation and mindfulness exercises to
benefit women with sexual arousal and pain diffi-
culties [52–54]. However, these techniques have
not received much attention in the literature for
the treatment of sexual dysfunction and may
present as a rich and largely untapped area to
explore. Importantly, as affective experiences are
complex and interrelated, increasing positive affect
and teaching mindfulness and relaxation tech-
niques are likely to benefit overall female sexual
response.
Conclusions
Changes in female sexual response are closely tied
to day-to-day fluctuations in happiness, enthusi-
asm, calmness, and fear. Importantly, these daily
changes in sexual function and affect predomi-
nantly occur simultaneously, suggesting that they
may, in part, represent manifestations of the same
facilitating mechanisms. Future directions in
research on normative and pathological affect and
sexual response should focus on identifying under-
lying neurobiological, physiological, and cognitive
processes related to changes in both affective expe-
riences and female sexual functioning.
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